Nomenclature
•Pituitary
–Greek
•ptuo (to spit)
–Latin
•Pituita (mucus)
–Mucus was produced
by the brain and was
excreted through the
nose by the pituitary
Pituitary Development
• Evagination of the stromodeal ectoderm from buccal cavity
• Infundibulum, neural stalk and posterior lobe from diencephalon
• Development 3
rd
to the 15
th
week gestation
Pituitary Anatomy
Gross
•Sits in sella turcica
•Surrounded by dura
•Sphenoid
–Lateral and inferior
•Lateral
–Cavernous sinus
•Internal carotid artery
•CN III, IV, VI,
V1 and V2
Pituitary Anatomy
Gross
•Symmetrical bean
shaped
–Brownish red
•13 mm transverse
•9 mm AP
•6 mm height
•Adult
–0.4-0.9 grams
–Larger in women
–Larger in multiparous
women
–During pregnancy
increases to 0.9-1 grams
•Anterior lobe
–80% of gland
–Brown color
•Posterior lobe
– Gray/brown color
Pituitary Anatomy
Microscopic
Pituitary Anatomy
Microscopic
•Anterior lobe 3 divisions
–Pars distalis
•Largest
•Hormone producing cells
–Pars intermedia
•Poorly defined in the human
–Pars tuberalis
•Upward extension to the
anterior lobe and attached
to pituitary stalk
•Posterior lobe
–Pars nervosa
TRH
(+)
HYPOTHALAMUS
ANTERIOR
PITUITARY
HYPOTHALAMIC-
PITUITARY
PORTAL SYSTEM
T4, T3 (T4 --> T3)
THYROID GLAND
TSH
POSTERIOR
PITUITARY
(-)
(-)
POSTERIOR
PITUITARY
PRL
BREAST
PRIH
(-)
HYPOTHALAMUS
ANTERIOR
PITUITARY
(DOPAMINE)
POSTERIOR
PITUITARYANTERIOR
PITUITARY
LH, FSH
SEX HORMONES, INHIBIN
GONAD
(-)
(-)GnRH
(+)
HYPOTHALAMUS
HYPOTHALAMIC-
PITUITARY
PORTAL SYSTEM
(LHRH)
Posterior pituitary
Hypothalamic
source (cell body)Target Effect
ADH Collecting H
2
O retention
duct
Oxytocin Breast Milk let down
Uterus Smooth muscle
Contraction
History
•15yr old WF presents with secondary
amenorrhea, polydipsia and polyuria
•Normal growth and development
•Menarche at 11 years of age
–Qmonth menses until 12 years of age
–Withdrawal bleeding only with OCP’s
History
•Drinks 32 oz water Q3-
4hrs during the day
•Drinks and urinates Q2-
3hrs at night
•ROS: occasional
headaches, fatigue and
difficulty losing weight
Physical Exam
•Wt 62.9kg (75%)
•Ht 5ft 3.5in (50%)
•BMI 24.2 kg/m
2
•HR 80
•B/P 117/86
•General:
nondysmorphic, well-
nourished
•HEENT: visual fields
intact, no thyromegaly
•Breast: no discharge,
Tanner V
•GU: Tanner V
Hypopituitary
Presentation
•Growth hormone
production
–First hormone to be
disrupted
•Gonadotropin
deficiency
–Easily disrupted
•Corticotropin
–Less frequently
affected
•Thyrotropin
–Rarely affected
•Anti-diuretic hormone
–Deficiency usually due
to tumor
–Craniopharyngioma
Hypopituitary
Presentation
•Growth hormone
deficiency
–Children
•Short stature
–Adults
•Non specific
•Fine wrinkling around the
face
•Improved insulin sensitivity
Hypopituitary
Presentation
•Gonadotropin deficiency
–Women
•Amenorrhea
–Primary or secondary
•Infertility
–Men
•Decreased libido
•Decreased beard and body
hair
Hypopituitary
Presentation
•Corticotropin deficiency
–Fatigue
–Decreased appetite
–Weight loss
–Decreased pigmentation
–Abnormal response to
stress
•Hypotension
•Hyponatremia
•Fever
•Primary Adrenal
Insufficiency
–Addison’s disease
–Fatigue
–Decreased appetite
–Weight loss
–Increased pigmentation
–Hyperkalemia
–Abnormal response to
stress
•Hypotension
•Hyponatremia
•Fever
Laboratory
•FSH 6.9 mIU/ml (Tanner V 1.0-9.2)
•LH 7.1 mIU/ml (Tanner V 0.4-11.7)
•IGF-1 207 ng/ml (217-589)
•Skeletal Xray: no lesions and
epiphyses closed.
•Dopamine arginine GH stimulation test
<5ng/ml
Treatment
•Growth hormone therapy
•Estrogen and progesterone
–Birth control pills
•Testosterone
–Cypianate or enanthate
•200 mg IM Q2 weeks
–Gels 5-10 gram per day
•Fertility
–Refer to Reproductive
Endocrinologist
•Thyroid
–Levothyroxine (generic)
–Synthroid
–Levoxyl
–Unithroid
•Dose ranges 75-150 mcg per
day
Treatment
•Cortisol
–Hydrocortisone
•10mg AM and 5 mg PM
•6-8 mg/m
2
/day
•Stress dosing
–Fever, illness, surgery
–20 mg/m
2
/day
–Double or triple daily dose
–100 mg x1 then 25-50 mg
Q6-8hrs
•All hypopituitary patients
need a medic alert
bracelet
Treatment
•Desmopressin
(DDAVP)
–Nasal spray
•10 mcg QD-BID
–Tablets
•0.1 to 0.2 mg QD-BID
–SQ injection
•1-2 ug QD-BID